1. Intracellular transport of inositol-containing sphingolipids in the yeast, Saccharomyces cerevisiae.
- Author
-
Hechtberger P and Daum G
- Subjects
- Biological Transport, Brefeldin A, Cell Membrane metabolism, Cycloheximide pharmacology, Cyclopentanes pharmacology, Endoplasmic Reticulum drug effects, Golgi Apparatus drug effects, Inositol metabolism, Nocodazole pharmacology, Saccharomyces cerevisiae drug effects, Saccharomyces cerevisiae growth & development, Ceramides metabolism, Endoplasmic Reticulum metabolism, Golgi Apparatus metabolism, Saccharomyces cerevisiae metabolism
- Abstract
Organelles of the early protein secretion pathway (ER, Golgi) are involved in biosynthesis and intracellular migration of the yeast sphingolipids, inositolphosphorylceramide (IPC), mannosylinositolphosphorylceramide (MIPC), and mannosyldiinositolphosphorylceramide (M(IP)2C). Cycloheximide and nocodazole neither block biosynthesis of sphingolipids, nor ER to Golgi transport of IPC. In contrast, treatment of yeast cells with brefeldin A, which affects integrity of the Golgi, decreases formation of IPC and MIPC. Interruption of late steps of protein secretion (Golgi to plasma membrane transport) in temperature-sensitive secretory mutants prevents sphingolipids from being transported to the cell periphery.
- Published
- 1995
- Full Text
- View/download PDF